Fluidigm Corporation
Diagnostics & Research
Healthcare
FLDM
76.30M shares
NASDAQ US
traded
05 Apr 2022
listed
yes
open
4.05
52 week high
7.41
high
4.05
52 week low
2.80
low
3.66
growth
-19.87%
previous Close
3.99
P/E ratio
-31
market cap
258M
div yield
0
usd
Dec 2021
qoq
revenue
38.27M
34.24 %
net incoming
-9.43M
31.89 %
eps
-0.12
33.33 %
eps surprise
57.14 %
net profit margin
-24.64 %
23.00 %
operating incoming
-11.26M
42.59 %
net change in cash
cash on hand
28.45M
-2.93 %
cost of revenue
36.05M
21.49 %
top top